There is strong evidence that sorafenib induces apoptosis predominantly in cancer cells, but significant cell death can be induced in non-cancer cells through the robust expression of p53-upregulated-modulator-of-apoptosis (PUMA) [42]. The gene discussed is TP53; the disease is cancer.